The Immune-Nanomedicine Axis in Glioblastoma: From Biomimetic Delivery to Immune Reprogramming
International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-32
DOI: 10.2147/ijn.s655635 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Yipu Shao. Beteiligte Einrichtung: Intensive Care Unit, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471023, Peop…. Hauptthemen laut MEDLINE: Glioblastoma, Nanomedicine, Brain Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Intensive Care Unit, The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Luoyang, 471023, People's Republic of China.
ORCID-Profile: Yipu Shao
Zitieren
APA
Shao, Y. (2026). The Immune-Nanomedicine Axis in Glioblastoma: From Biomimetic Delivery to Immune Reprogramming. International Journal of Nanomedicine, Volume 21, 1-32. https://doi.org/10.2147/ijn.s655635
Vancouver
Shao Y. The Immune-Nanomedicine Axis in Glioblastoma: From Biomimetic Delivery to Immune Reprogramming. International Journal of Nanomedicine. 2026;Volume 21:1-32. doi:10.2147/ijn.s655635
BibTeX
@article{Shao2026,
author = {Shao, Yipu},
title = {The Immune-Nanomedicine Axis in Glioblastoma: From Biomimetic Delivery to Immune Reprogramming},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--32},
doi = {10.2147/ijn.s655635}
}
EUVIMED